Analysts consensus on solvar has been rerated to 3 strong buy,
seems like the worst is behind us and from now on business is forward looking.
- Forums
- ASX - By Stock
- Ann: FY24 Results Investor Presentation
SVR
solvar limited
Add to My Watchlist
0.90%
!
$1.68

Analysts consensus on solvar has been rerated to 3 strong buy,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.68 |
Change
0.015(0.90%) |
Mkt cap ! $329.0M |
Open | High | Low | Value | Volume |
$1.62 | $1.70 | $1.62 | $737.0K | 437.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2458 | $1.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 3021 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 924 | 1.845 |
1 | 186 | 1.760 |
1 | 57 | 1.740 |
1 | 54 | 1.725 |
5 | 7245 | 1.720 |
Price($) | Vol. | No. |
---|---|---|
1.640 | 294 | 1 |
1.670 | 3745 | 1 |
1.680 | 3022 | 3 |
1.685 | 3668 | 2 |
1.700 | 22353 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online